Radial access and risk guided use of bivalirudin?-Reference-Cited by-同舟云学术

Radial access and risk guided use of bivalirudin?

Published:2020-11 Issue:6 Volume:96 Page:1249-1250
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Ashley Kellan E.¹²,Hillegass William B.²³^ORCID

Affiliation:

1. Departments of Interventional Cardiovascular Disease University of Mississippi Medical Center Jackson Mississippi USA

2. Departments of Medicine University of Mississippi Medical Center Jackson Mississippi USA

3. Departments of Data Science University of Mississippi Medical Center Jackson Mississippi USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29358

Reference5 articles.

1. Meta‐analysis of bivalirudin versus heparin in transradial coronary interventions

2. StoneGW ErlineD ValgimigliM HanY StegPG KastratiA et al.Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction. October.2020. Retrieved fromhttps://www.tctmd.com/news/bivalirudin-vs-heparin-patient-level-meta-analysis-stirs-old-debate.

3. Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding

4. Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses;Hillegass WB;J Thorac Dis,2016

5. Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials